Activation Induced Cytidine Deaminase
Activation Induced Cytidine Deaminase - Related Videos
02:58
CRISPR-Mediated Base Editing Tools: A Genome Editing Technique to Induce Targeted Base Substitution
0 Views •
2025
This video explains the concept of CRISPR-mediated cytosine base editors for inducing targeted nucleotide substitution.
08:08
An Assay for Measuring the Activity of Escherichia coli Inducible Lysine Decarboxyase
0 Views •
Cited by 7 •
2010
The activity of the inducible lysine decarboxylase is monitored by reacting the substrate L-lysine and the product cadaverine with 2,4,6-trinitrobenzensulfonic acid to form adducts that have differential solubility in toluene.
04:17
Determining the Serum Stability of Human Adenosine Deaminase 1 Enzyme
0 Views •
2024
In this article, we detail methods to characterize an enzyme's ability to retain function when incubated at 37 °C in human serum, a pharmacological property referred to as its serum stability. This ability may be a key factor in predicting an enzyme's pharmacokinetic profile and its suitability for therapeutic use.
06:10
Seizure Activity Induced by Electroshock in Drosophila Larvae
0 Views •
2025
This protocol details the use of Drosophila larvae to identify unique antiseizure compounds for the treatment of epilepsy.
05:15
Monitoring Seizure-Induced Neural Electrical Activity in Brain Slices Using Microelectrode Arrays
0 Views •
2025
This protocol involves using a microelectrode array (MEA) to record electrical activity in a brain slice exposed to a seizure-inducing drug. The procedure includes positioning the brain slice in an MEA recording chamber, applying electrical stimulation to induce artificial seizures, and analyzing the resulting signals.
FAQs
Transcription creates access to the exposed single-stranded DNA that AID targets in activated B cells. The enzyme converts cytidine bases in this DNA to uridine, initiating lesions in the immunoglobulin genetic material. This substrate preference connects gene transcription with the controlled DNA changes required for antibody diversification during an immune response.
The resulting uridine-containing changes are processed by DNA repair pathways rather than becoming antibody changes immediately. Depending on how these lesions are handled, processing can produce mutations or targeted recombination. This repair-dependent step is important because it determines whether an activated B cell alters antibody affinity through somatic hypermutation or changes antibody class through class-switch recombination.
Somatic hypermutation introduces mutations that can improve antibody affinity, whereas class-switch recombination changes the antibody isotype. The two outcomes therefore affect different properties of the antibody response. One modifies how strongly an antibody may bind its antigen, while the other changes its class without altering antigen specificity, allowing diversification to support distinct immune-response requirements.
A conceptual analysis follows activated B cells from transcription through DNA targeting, cytidine-to-uridine conversion, lesion processing, and the resulting antibody change. Researchers can then distinguish mutation-associated outcomes from targeted recombination and relate each to altered affinity or isotype. This sequence provides a framework for interpreting how molecular events generate functional antibody diversity.
AID supports infection defense by enabling antibody diversification in adaptive immunity. Its activity can contribute to somatic hypermutation, which improves antibody affinity, and class-switch recombination, which changes antibody isotype while preserving antigen specificity. Studying these outcomes helps explain how B-cell responses adapt during infection and how effective antibody-mediated protection develops.
AID research helps connect molecular DNA changes in activated B cells with the development of immune memory. It also provides a way to examine how pathogens shape antibody responses through diversification. These perspectives are relevant to immunology and infection because they link antigen exposure with changes in antibody affinity and isotype over the course of an immune response.
AID dysregulation can have consequences beyond normal antibody diversification. The overview links abnormal activity with immunodeficiency, autoimmunity, and B-cell malignancies, showing that its effects depend on appropriate control. Consequently, studying AID is relevant not only to protective infection responses but also to understanding disease states in which antibody diversification or B-cell biology becomes disrupted.